Skip to content

Low Salt Diet

DIETARY_SUPPLEMENT11 trials

Sponsors

Organon and Co, University of Michigan, University of Parma, Vanderbilt University, Yale University

Conditions

Autoimmune HepatitisAutoimmunityBlood PressureCKD ProgressionCardiometabolic DiseasesEndolymphatic HydropsEustachian Tube DysfunctionHypercalciuria

Phase 2

Phase 3

Phase 4

Unknown Phase

Lowering Salt Intake in Chronic Kidney Disease: A Pilot Randomized Crossover Trial
CompletedNCT00974636
University of MichiganKidney Disease
Start: 2009-05-31End: 2013-05-31Updated: 2015-08-05
The Links Between Water and Salt Intake, Body Weight, Hypertension and Kidney Stones: a Difficult Puzzle
NCT01100580
University of ParmaHypertension, Obesity, Overweight +1
Start: 2010-05-31End: 2012-05-31Target: 350Updated: 2010-04-09
Refractory Eustachian Tube Dysfunction: Are the Symptoms Related to Endolymphatic Hydrops
WithdrawnNCT01661777
Vanderbilt UniversityEndolymphatic Hydrops, Eustachian Tube Dysfunction
Start: 2012-08-31End: 2013-08-31Updated: 2014-05-29
The Role of Sodium Chloride and the Treg/Th17 Axis in Autoimmune Hepatitis
CompletedNCT02050646
Yale UniversityAutoimmune Hepatitis
Start: 2013-08-27End: 2021-06-30Updated: 2021-07-28
Salt and TH-17 in Healthy Human Subjects
TerminatedNCT02261688
Brigham and Women's HospitalAutoimmunity, Salt Intake, Sodium Chloride +1
Start: 2014-03-31End: 2019-08-31Updated: 2021-06-08
CARDIA-Salt Sensitivity of Blood Pressure (SSBP)
CompletedNCT04258332
Vanderbilt University Medical CenterHypertension, Salt Sensitivity of Blood Pressure
Start: 2021-05-17End: 2025-05-17Updated: 2025-08-22
Effect of Low Salt and Ckd Progression
CompletedNCT05716386
Bangkok Metropolitan Administration Medical College and Vajira HospitalBlood Pressure, CKD Progression, Proteinuria
Start: 2023-02-28End: 2023-08-31Updated: 2023-09-01
Genetic Architecture of Natriuretic Peptides and Blood Pressure Response
Not yet recruitingNCT07118592
University of Alabama at BirminghamCardiometabolic Diseases, Hypertension (HTN)
Start: 2026-09-01End: 2030-12-01Target: 200Updated: 2026-03-10

Related Papers